Search Results - Irlam-Jones, Joely

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer

    A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer by Khan, Mairah T., Irlam-Jones, Joely J., Pereira, Ronnie Rodrigues, Lane, Brian, Valentine, Helen R., Aragaki, Kai, Dyrskjøt, Lars, McConkey, David J., Hoskin, Peter J., Choudhury, Ananya, West, Catharine M. L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue

    Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue by Smith, Tim A. D., AbdelKarem, Omneya A., Irlam-Jones, Joely J., Lane, Brian, Valentine, Helen, Bibby, Becky A. S., Denley, Helen, Choudhury, Ananya, West, Catharine M. L.

    Published in Scientific reports
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial

    A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial by Smith, Tim A.D., West, Catharine M.L., Joseph, Nuradh, Lane, Brian, Irlam-Jones, Joely, More, Elisabet, Mistry, Hitesh, Reeves, Kimberley J., Song, Yee Pei, Reardon, Mark, Hoskin, Peter J., Hussain, Syed A., Denley, Helen, Hall, Emma, Porta, Nuria, Huddart, Robert A., James, Nick D., Choudhury, Ananya

    Published in EBioMedicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trialResearch in context

    A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trialResearch in context by Tim A.D. Smith, Catharine M.L. West, Nuradh Joseph, Brian Lane, Joely Irlam-Jones, Elisabet More, Hitesh Mistry, Kimberley J. Reeves, Yee Pei Song, Mark Reardon, Peter J. Hoskin, Syed A. Hussain, Helen Denley, Emma Hall, Nuria Porta, Robert A. Huddart, Nick D. James, Ananya Choudhury

    Published in EBioMedicine
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract LB-450: Necrosis predicts benefit from hypoxia-modifying therapy in urothelial cell carcinoma of the bladder

    Abstract LB-450: Necrosis predicts benefit from hypoxia-modifying therapy in urothelial cell carcinoma of the bladder by Irlam-Jones, Joely J., Williamson, Amanda, Taylor, Janet, Denley, Helen, Agrawal, Shailesh, Choudhury, Ananya, Ryder, David, Rojas, Ana M., Hoskins, Peter J., Miller, Crispin J., Ord, Jonathan J., Harris, Adrian L., West, Catharine M.L.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: